2397 — DNA Chip Research Cashflow Statement
0.000.00%
Last trade - 00:00- ¥7bn
- ¥7bn
- ¥490m
Annual cashflow statement for DNA Chip Research, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -128 | -172 | -133 | -361 | -246 |
| Depreciation | |||||
| Non-Cash Items | 0.749 | 1.31 | 11.8 | 24.5 | 3.08 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -150 | 72.6 | 31.8 | -18 | 61.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -259 | -76 | -73 | -337 | -140 |
| Capital Expenditures | -53 | -51.4 | -58.7 | -126 | -15.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -42.2 | — | — | -29.3 | 0.085 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -95.2 | -51.4 | -58.7 | -155 | -15.8 |
| Financing Cash Flow Items | -1.44 | -0.001 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -1.44 | 446 | — | 278 | 269 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -356 | 318 | -132 | -214 | 113 |